NFX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.021850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.663200E-01
Normal-vs-Stage2
1.085840E-01
Normal-vs-Stage3
4.809800E-02
Normal-vs-Stage4
4.881000E-01
Stage1-vs-Stage2
3.355600E-01
Stage1-vs-Stage3
1.362880E-03
Stage1-vs-Stage4
6.127600E-01
Stage2-vs-Stage3
8.131600E-02
Stage2-vs-Stage4
1.089620E-01
Stage3-vs-Stage4
2.623300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.109410E-01
Normal-vs-AfricanAmerican
2.330000E-01
Normal-vs-Asian
7.266100E-02
Caucasian-vs-AfricanAmerican
9.164000E-01
Caucasian-vs-Asian
6.738200E-01
AfricanAmerican-vs-Asian
8.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.516410E-01
Normal-vs-Female
6.116100E-02
Male-vs-Female
5.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.656200E-01
Normal-vs-Age(41-60Yrs)
1.800980E-01
Normal-vs-Age(61-80Yrs)
9.684100E-02
Normal-vs-Age(81-100Yrs)
7.902000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.371000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.020000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.030800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.137800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.284800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.705200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.528030E-02
Normal-vs-Daily Drinker
1.879240E-01
Normal-vs-Weekly Drinker
2.460000E-01
Normal-vs-Occasional Drinker
1.861200E-01
Normal-vs-Social Drinker
3.401600E-01
Non Drinker-vs-Daily Drinker
4.493400E-01
Non Drinker-vs-Weekly Drinker
1.210650E-01
Non Drinker-vs-Occasional Drinker
5.628100E-02
Non Drinker-vs-Social Drinker
5.456500E-03
Daily Drinker-vs-Weekly Drinker
5.952000E-01
Daily Drinker-vs-Occasional Drinker
4.831400E-01
Daily Drinker-vs-Social Drinker
1.820810E-01
Weekly Drinker-vs-Occasional Drinker
9.255400E-01
Weekly Drinker-vs-Social Drinker
4.189200E-01
Occasional Drinker-vs-Social Drinker
4.034200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.653000E-01
Normal-vs-Grade 2
2.582800E-01
Normal-vs-Grade 3
2.756200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.902000E-01
Grade 1-vs-Grade 3
6.720400E-01
Grade 1-vs-Grade 4
2.653000E-01
Grade 2-vs-Grade 3
4.684400E-01
Grade 2-vs-Grade 4
2.582800E-01
Grade 3-vs-Grade 4
2.756200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.062500E-02
Normal-vs-NonDiabetic
7.385900E-02
Diabetic-vs-NonDiabetic
4.898800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.400300E-02
Normal-vs-NoPancreatitis
8.364100E-02
Pancreatitis-vs-NoPancreatitis
4.295800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.217220E-01
Normal-vs-N1
1.140820E-01
N0-vs-N1
7.331000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.808800E-01
Normal-vs-TP53-NonMutant
4.072800E-01
TP53-Mutant-vs-TP53-NonMutant
1.592630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
